• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Azithromycin in patients with COVID-19: Friend or foe?阿奇霉素用于新冠肺炎患者：是友还是敌？
Clin Microbiol Infect. 2021 Jan;27(1):136-137. doi: 10.1016/j.cmi.2020.09.047. Epub 2020 Sep 29.
2
Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.阿奇霉素联合羟氯喹治疗因 2019 冠状病毒病（COVID-19）入住重症监护病房的患者：随机对照试验 AZIQUINE-ICU 的方案。
Trials. 2020 Jul 8;21(1):631. doi: 10.1186/s13063-020-04566-x.
3
Additional safety consideration for azithromycin in the management of SARS-CoV-2 infection.阿奇霉素在治疗新型冠状病毒肺炎中的其他安全性考量。
CMAJ. 2020 May 4;192(18):E483. doi: 10.1503/cmaj.75427.
4
Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.回复：菲奥莱特等人所著的《羟氯喹啉联合或不联合阿奇霉素对COVID-19患者死亡率的影响》
Clin Microbiol Infect. 2021 Jan;27(1):134-135. doi: 10.1016/j.cmi.2020.09.027. Epub 2020 Sep 25.
5
Does hydroxychloroquine prevent the transmission of COVID-19?羟氯喹能预防新型冠状病毒肺炎的传播吗？
Ann Rheum Dis. 2020 Jun;79(6):e60. doi: 10.1136/annrheumdis-2020-217501. Epub 2020 Apr 15.
6
Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.羟氯喹啉和阿奇霉素对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒载量的不确定影响的反应。
Int J Antimicrob Agents. 2021 Jan;57(1):106244. doi: 10.1016/j.ijantimicag.2020.106244.
7
Claims about the safety and efficacy of early treatment of COVID-19 with hydroxychloroquine and azithromycin must be supported by real evidence.关于使用羟氯喹和阿奇霉素对新冠肺炎进行早期治疗的安全性和有效性的说法必须有真实证据支持。
Travel Med Infect Dis. 2020 Nov-Dec;38:101886. doi: 10.1016/j.tmaid.2020.101886. Epub 2020 Sep 25.
8
Taking the Longer View of COVID-19.从更长远的视角看待新冠疫情。
Oncologist. 2020 Jun;25(6):455-457. doi: 10.1634/theoncologist.2020-0313. Epub 2020 Apr 27.
9
Dangers of the use of hydroxychloroquine and azithromycin combination in COVID-19 patients.新冠病毒肺炎患者使用羟氯喹啉和阿奇霉素联合用药的风险
Travel Med Infect Dis. 2020 Nov-Dec;38:101881. doi: 10.1016/j.tmaid.2020.101881. Epub 2020 Sep 18.
10
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.对于重症新冠病毒感染患者，没有证据表明羟氯喹和阿奇霉素联合使用能实现快速的抗病毒清除或带来临床益处。
Med Mal Infect. 2020 Jun;50(4):384. doi: 10.1016/j.medmal.2020.03.006. Epub 2020 Mar 30.

引用本文的文献

1
Clinical and pharmacological factors associated with mortality in patients with COVID-19 in a high complexity hospital in Manaus: A retrospective study.临床和药理学因素与马瑙斯一家高复杂度医院 COVID-19 患者死亡率的相关性：一项回顾性研究。
PLoS One. 2023 Feb 10;18(2):e0280891. doi: 10.1371/journal.pone.0280891. eCollection 2023.
2
Vitamin D supplementation to treat SARS-CoV-2 positive patients. Evidence from meta-analysis.维生素 D 补充剂治疗 SARS-CoV-2 阳性患者。荟萃分析的证据。
Cardiol J. 2022;29(2):188-196. doi: 10.5603/CJ.a2021.0122. Epub 2021 Oct 13.
3
The Association Between the Use of Statins and Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-analysis.他汀类药物的使用与 COVID-19 患者临床结局的相关性：系统评价和荟萃分析。
Am J Cardiovasc Drugs. 2022 Mar;22(2):167-181. doi: 10.1007/s40256-021-00490-w. Epub 2021 Aug 3.

本文引用的文献

1
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.羟氯喹联合或不联合阿奇霉素对 COVID-19 患者死亡率的影响：系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Jan;27(1):19-27. doi: 10.1016/j.cmi.2020.08.022. Epub 2020 Aug 26.
2
Association of Azithromycin Use With Cardiovascular Mortality.阿奇霉素使用与心血管死亡率的关联。
JAMA Netw Open. 2020 Jun 1;3(6):e208199. doi: 10.1001/jamanetworkopen.2020.8199.
3
Azithromycin Causes a Novel Proarrhythmic Syndrome.阿奇霉素会引发一种新型的心律失常综合征。
Circ Arrhythm Electrophysiol. 2017 Apr;10(4). doi: 10.1161/CIRCEP.115.003560.
4
Cardiovascular events and safety outcomes associated with azithromycin therapy: a meta-analysis of randomized controlled trials.阿奇霉素治疗相关的心血管事件和安全性结局：随机对照试验的荟萃分析
Am Health Drug Benefits. 2014 Sep;7(6):318-28.
5
Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.尽管大环内酯类抗生素导致的QT间期延长相似，但它们的促心律失常潜力却不同：快速复极3期可预防早期后除极和尖端扭转型室速。
J Pharmacol Exp Ther. 2002 Oct;303(1):218-25. doi: 10.1124/jpet.102.037911.

Azithromycin in patients with COVID-19: Friend or foe?

作者信息

Kow Chia Siang, Hasan Syed Shahzad

机构信息

School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.

Department of Pharmacy, University of Huddersfield, Huddersfield, UK; School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.

出版信息

Clin Microbiol Infect. 2021 Jan;27(1):136-137. doi: 10.1016/j.cmi.2020.09.047. Epub 2020 Sep 29.

DOI:10.1016/j.cmi.2020.09.047
PMID:33007473
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7524443/
Abstract
摘要